CDKN2A and oligodendroglioma: Transgenic mice expressing v-erbB, a transforming allele of EGFR driven by the S100β promoter, develop low-grade oligodendroglioma, and mice with ink4a/arf or p53 heterozygous mutations develop high-grade tumors 90.